CACH Syndrome
Symptoms, Doctors, Treatments, Advances & More

Learn About CACH Syndrome

What is the definition of CACH Syndrome?

Leukoencephalopathy with vanishing white matter is a progressive disorder that mainly affects the brain and spinal cord (central nervous system). This disorder causes deterioration of the central nervous system's white matter, which consists of nerve fibers covered by myelin. Myelin is the fatty substance that insulates and protects nerves.

What are the causes of CACH Syndrome?

Mutations in the EIF2B1, EIF2B2, EIF2B3, EIF2B4, and EIF2B5 genes cause leukoencephalopathy with vanishing white matter.

How prevalent is CACH Syndrome?

The prevalence of leukoencephalopathy with vanishing white matter is unknown. Although it is a rare disorder, it is believed to be one of the most common inherited diseases that affect the white matter.

Is CACH Syndrome an inherited disorder?

This condition is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.

Who are the top CACH Syndrome Local Doctors?
Joshua Bonkowsky
Elite in CACH Syndrome
Elite in CACH Syndrome

Pediatric Nephrology - University Of Utah Hospital

50 N Medical Dr, 
Salt Lake City, UT 
Experience:
28+ years
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Dr. Josh Bonkowsky is an associate professor of Pediatric Neurology (Pediatrics) and of Neurology. He obtained his MD and PhD degrees at the University of California. His undergraduate training was at Harvard University, and his Pediatrics and Neurology/Pediatric Neurology training was at the University of Utah and Boston Children's Hospital. His clinical studies are focused on understanding clinical features of leukodystrophies and genetics of complex human neurobehavioral traits, especially language impairments. Dr. Bonkowsky's clinical research group is investigating genetics of leukodystrophies to understand the genetic and medical impacts of these disorders. The Bonkowsky Laboratory is generating disease models for high-throughput drug discovery and investigating human neurogenetic diseases, specifically diseases of basal ganglia function and white matter diseases. On sunny afternoons, Dr. Bonkowsky enjoys trail running and learning to skate ski. Dr. Bonkowsky is rated as an Elite provider by MediFind in the treatment of CACH Syndrome. His top areas of expertise are CACH Syndrome, Adrenoleukodystrophy (ALD), Leukodystrophy, Krabbe Disease, and Gastrostomy.

Igor J. Koralnik
Elite in CACH Syndrome
Elite in CACH Syndrome

Regenstein Center For Neurological Care - Lavin Family Pavilion

259 E Erie St, Ste 1900, 
Chicago, IL 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Igor Koralnik is a Neurologist in Chicago, Illinois. Dr. Koralnik is rated as an Elite provider by MediFind in the treatment of CACH Syndrome. His top areas of expertise are Progressive Multifocal Leukoencephalopathy, CACH Syndrome, Encephalitis, Thrombectomy, and Endovascular Embolization. Dr. Koralnik is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in CACH Syndrome
Neuroradiology
Elite in CACH Syndrome
Neuroradiology

Johns Hopkins Hospital

600 N Wolfe St, 
Baltimore, MD 
Languages Spoken:
English

Daniel Reich is a Neuroradiologist in Baltimore, Maryland. Dr. Reich is rated as an Elite provider by MediFind in the treatment of CACH Syndrome. His top areas of expertise are Multiple Sclerosis (MS), CACH Syndrome, Progressive Multifocal Leukoencephalopathy, and Encephalitis.

What are the latest CACH Syndrome Clinical Trials?
CurePML - Allogeneic HPyV-2-specific T-cell Therapy in Patients With Progressive Multifocal Leukoencephalopathy

Summary: There is no approved standard treatment für progressive multifocal leukoencephalopathy (PML). The sponsor of the study is developing a new treatment. For this reason, the investigational medicinal product (IMP) called 'human allogenic HPyV-2-specific T cells' is to be tested in this study. The sponsor wants to find out whether the IMP is safe, influences the neurological status and improves the qu...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase Ib Study of Nivolumab in Patients With Autoimmune Disorders and Advanced Malignancies (AIM-NIVO)

Summary: This phase Ib trial studies the side effects of nivolumab and to see how well it works in treating patients with autoimmune disorders and cancer that has spread to other places in the body or cannot removed by surgery. Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and sprea...

Who are the sources who wrote this article ?

Published Date: May 01, 2013
Published By: National Institutes of Health